Cargando…

Exploring C-peptide loss in type 1 diabetes using growth curve analysis

OBJECTIVES: C-peptide (CP) loss in type 1 diabetes (T1D) is highly variable, and factors influencing it are poorly understood. We modelled CP values in T1D patients from diagnosis for up to 6 years, treating the serial data as growth curves plotted against time since diagnosis. The aims were to summ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Besser, Rachel E. J., Ludvigsson, Johnny, Hindmarsh, Peter C., Cole, Tim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6029769/ https://www.ncbi.nlm.nih.gov/pubmed/29969494 http://dx.doi.org/10.1371/journal.pone.0199635

Ejemplares similares

Lessons From the Mixed-Meal Tolerance Test: Use of 90-minute and fasting C-peptide in pediatric diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2013)

Response to Comment on: Besser et al. Lessons From the Mixed-Meal Tolerance Test: Use of 90-Minute and Fasting C-Peptide in Pediatric Diabetes. Diabetes Care 2013;36:195–201
por: Shields, Beverley M., et al.
Publicado: (2013)

Urine C-Peptide Creatinine Ratio Is a Noninvasive Alternative to the Mixed-Meal Tolerance Test in Children and Adults With Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

Higher risk of severe hypoglycemia in children and adolescents with a rapid loss of C-peptide during the first 6 years after type 1 diabetes diagnosis
por: Grönberg, Annika, et al.
Publicado: (2022)

Association between treatment effect on C‐peptide preservation and HbA1c in meta‐analysis of glutamic acid decarboxylase (GAD)‐alum immunotherapy in recent‐onset type 1 diabetes
por: Nowak, Christoph, et al.
Publicado: (2022)

Effect of COVID‐19 pandemic on treatment of Type 1 diabetes in children
por: Ludvigsson, Johnny
Publicado: (2020)

Autoantigen Treatment in Type 1 Diabetes: Unsolved Questions on How to Select Autoantigen and Administration Route
por: Ludvigsson, Johnny
Publicado: (2020)

Physical Activity, Blood Glucose and C-Peptide in Healthy School-Children, a Longitudinal Study
por: Huus, Karina, et al.
Publicado: (2016)

SITAR—a useful instrument for growth curve analysis
por: Cole, Tim J, et al.
Publicado: (2010)

Teplizumab Preserves C-Peptide in Recent-Onset Type 1 Diabetes: Two-Year Results From the Randomized, Placebo-Controlled Protégé Trial
por: Hagopian, William, et al.
Publicado: (2013)

A Population-Based Study of the Risk of Diabetic Retinopathy in Patients With Type 1 Diabetes and Celiac Disease
por: Mollazadegan, Kaziwe, et al.
Publicado: (2013)

Type 1 diabetes in low and middle-income countries - Tanzania a streak of hope
por: Ludvigsson, Johnny, et al.
Publicado: (2023)

Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration
por: Carr, Alice L.J., et al.
Publicado: (2022)

Urinary C‐peptide creatinine ratio detects absolute insulin deficiency in Type 2 diabetes
por: Hope, S. V., et al.
Publicado: (2013)

Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study
por: Oram, Richard A, et al.
Publicado: (2013)

Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes
por: Pacaud, Danièle, et al.
Publicado: (2020)

Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes
por: Hannelius, Ulf, et al.
Publicado: (2020)

Islet amyloid in recent-onset type 1 diabetes—the DiViD study
por: Westermark, Gunilla T., et al.
Publicado: (2017)

Insulin-Like Growth Factor-1 at Diagnosis and during Subsequent Years in Adolescents with Type 1 Diabetes
por: Chisalita, Simona I., et al.
Publicado: (2018)

No association between incidence of type 1 diabetes and rotavirus vaccination in Swedish children
por: Rangert, Amanda, et al.
Publicado: (2023)

Fulminant Type 1 Diabetes as a Model of Nature to Explore the Role of C-Peptide
por: Murase-Mishiba, Yuko, et al.
Publicado: (2008)

HbA(1c) level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study
por: Lind, Marcus, et al.
Publicado: (2019)

Urinary C-Peptide Creatinine Ratio Is a Practical Outpatient Tool for Identifying Hepatocyte Nuclear Factor 1-α/Hepatocyte Nuclear Factor 4-α Maturity-Onset Diabetes of the Young From Long-Duration Type 1 Diabetes
por: Besser, Rachel E.J., et al.
Publicado: (2011)

A multicenter observational safety study in Swedish children and adolescents using insulin detemir for the treatment of type 1 diabetes
por: Carlsson, Annelie, et al.
Publicado: (2013)

Serum miRNA levels are related to glucose homeostasis and islet autoantibodies in children with high risk for type 1 diabetes
por: Åkerman, Linda, et al.
Publicado: (2018)

Mass Cytometry Identifies Distinct Subsets of Regulatory T Cells and Natural Killer Cells Associated With High Risk for Type 1 Diabetes
por: Barcenilla, Hugo, et al.
Publicado: (2019)

C-Peptide as a Therapy for Type 1 Diabetes Mellitus
por: Washburn, Rachel L., et al.
Publicado: (2021)

Increase of Neutrophil Extracellular Traps, Mitochondrial DNA and Nuclear DNA in Newly Diagnosed Type 1 Diabetes Children but Not in High-Risk Children
por: Skoglund, Camilla, et al.
Publicado: (2021)

Intralymphatic Glutamic Acid Decarboxylase-Alum Administration Induced Th2-Like-Specific Immunomodulation in Responder Patients: A Pilot Clinical Trial in Type 1 Diabetes
por: Tavira, Beatriz, et al.
Publicado: (2018)

Antibodies to post-translationally modified insulin as a novel biomarker for prediction of type 1 diabetes in children
por: Strollo, Rocky, et al.
Publicado: (2017)

Early Electrophysiological Abnormalities and Clinical Neuropathy: A prospective study in patients with type 1 diabetes
por: Hyllienmark, Lars, et al.
Publicado: (2013)

Glutamic Acid Decarboxylase Injection Into Lymph Nodes: Beta Cell Function and Immune Responses in Recent Onset Type 1 Diabetes Patients
por: Casas, Rosaura, et al.
Publicado: (2020)

C-Peptide-Positive, Autoantibody-Negative Type 1 Diabetes Mellitus
por: Fenner, Rachel M, et al.
Publicado: (2022)

Curve Appeal: Exploring Individual Differences in Preference for Curved Versus Angular Objects
por: Cotter, Katherine N., et al.
Publicado: (2017)

Intralymphatic glutamic acid decarboxylase administration in type 1 diabetes patients induced a distinctive early immune response in patients with DR3DQ2 haplotype
por: Puente-Marin, Sara, et al.
Publicado: (2023)

Low maternal education increases the risk of Type 1 Diabetes, but not other autoimmune diseases: a mediating role of childhood BMI and exposure to serious life events
por: White, Pär Andersson, et al.
Publicado: (2023)

The relationship between Insulin‐like Growth Factor 1, sex steroids and timing of the pubertal growth spurt
por: Cole, T.J., et al.
Publicado: (2015)

Type 1 Diabetic Neuropathy and C-peptide
por: Sima, Anders A. F., et al.
Publicado: (2004)

Cellular and Humoral Immune Responses in Type 1 Diabetic Patients Participating in a Phase III GAD-alum Intervention Trial
por: Axelsson, Stina, et al.
Publicado: (2013)

Severe COVID-19 Infection in Type 1 and Type 2 Diabetes During the First Three Waves in Sweden
por: Edqvist, Jon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_co2lgr4nvf94ecpi42q3f4mgqp